Diabetic kidney disease in patients with type 2 diabetes mellitus: a cross-sectional study

[1] Brown DW(2009)Projected burden of chronic, noncommunicable diseases in Jordan Prev Chronic Dis. 6 A78-808

[2] Mokdad AH(1999)End-stage renal failure in type 2 diabetes: a medical catastrophe of worldwide dimensions Am J Kidney Dis 34 795-26

[3] Walke H(2017)Classification and differential diagnosis of diabetic nephropathy J Diabetes Res 2017 8637138-56

[4] As’ad M(2005)An alarmingly high prevalence of diabetic nephropathy in Asian type 2 diabetic patients: the MicroAlbuminuria Prevalence (MAP) Study Diabetologia. 48 17-2883

[5] Al-Nsour M(2015)Diabetic kidney disease: world wide difference of prevalence and risk factors J Nephropharmacol 5 49-150

[6] Zindah M(2014)Diabetic kidney disease: a report from an ADA consensus conference Diabetes Care 37 2864-830

[7] Arqoob K(2013)Kidney disease: improving global outcomes (KDIGO) CKD work group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease Kidney Int Suppl 3 1-214

[8] Belbeisi A(2013)Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline Ann Intern Med 158 825-120

[9] Ritz E(2004)Significance of proteinuria in type 2 diabetic patients treated at a primary health care center in Abha City, Saudi Arabia West Afr J Med 23 211-51

[10] Rychlík I(1994)Prevalence of microalbuminuria in Saudi Arabians with non-insulin-dependent diabetes mellitus: a clinic-based study Diabetes Res Clin Pract 26 115-425

[1] Brown DW(2009)Projected burden of chronic, noncommunicable diseases in Jordan Prev Chronic Dis. 6 A78-808

[2] Mokdad AH(1999)End-stage renal failure in type 2 diabetes: a medical catastrophe of worldwide dimensions Am J Kidney Dis 34 795-26

[3] Walke H(2017)Classification and differential diagnosis of diabetic nephropathy J Diabetes Res 2017 8637138-56

[4] As’ad M(2005)An alarmingly high prevalence of diabetic nephropathy in Asian type 2 diabetic patients: the MicroAlbuminuria Prevalence (MAP) Study Diabetologia. 48 17-2883

[5] Al-Nsour M(2015)Diabetic kidney disease: world wide difference of prevalence and risk factors J Nephropharmacol 5 49-150

[6] Zindah M(2014)Diabetic kidney disease: a report from an ADA consensus conference Diabetes Care 37 2864-830

[7] Arqoob K(2013)Kidney disease: improving global outcomes (KDIGO) CKD work group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease Kidney Int Suppl 3 1-214

[8] Belbeisi A(2013)Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline Ann Intern Med 158 825-120

[9] Ritz E(2004)Significance of proteinuria in type 2 diabetic patients treated at a primary health care center in Abha City, Saudi Arabia West Afr J Med 23 211-51

[10] Rychlík I(1994)Prevalence of microalbuminuria in Saudi Arabians with non-insulin-dependent diabetes mellitus: a clinic-based study Diabetes Res Clin Pract 26 115-425